November 2018

Investing in STD Prevention: Making the Case for Your Jurisdiction

November 11, 2018

ASTHO and NCSD jointly released a customizable factsheet that can be used to present outputs from CDC’s STD Prevention Allocation Consequences Estimator in a format that is accessible to decisionmakers, the media, and local audiences. Update this customizable factsheet with your organization’s logo and local data to describe the health impacts of STD program budget changes in your jurisdiction.Read More »

States Work Across Agencies to Inform Opioid Prescribing Practices

November 02, 2018

This brief describes how Pennsylvania and Virginia advanced regulatory measures to address substance use disorder prevention and treatment with a focus on opioid prescribing practices and provider education.Read More »

Tobacco 21: Legislative Policy Analysis

October 04, 2018

This brief examines how several jurisdictions took different approaches to structuring their Tobacco 21 laws, including differences in penalties, enforcement provisions, and age-related exemptions.Read More »

Improving Access to Nonopioid Pain Management

September 25, 2018

This brief highlights evidence supporting the use of nonopioid medications and nonpharmacological interventions for pain management and outlines considerations for states looking to expand the use of these nonopioid alternatives.Read More »

PHAB Accreditation Impact Infographic Series

August 16, 2018

This four-part infographic series, developed by ASTHO with support from CDC’s Center for State, Tribal, Local, and Territorial Support (CSTLTS), illustrates successes from six state health departments to show how Public Health Accreditation Board (PHAB) accreditation positively influenced agency processes, programs, and infrastructure.Read More »

HPV Vaccine: Long-Lasting Cancer Protection

August 01, 2018

Vaccinations can prevent over 90 percent of cancers related to human papillomavirus (HPV). This customizable infographic is intended to help states raise awareness about the importance of the HPV vaccination as a safe, recommended public health strategy to reduce cancer risk.Read More »